Skip to main content
Premium Trial:

Request an Annual Quote

Med BioGene Posts $1.7M in Revenues for Q3

NEW YORK (GenomeWeb News) – Med BioGene today reported third-quarter revenues of C$1.7 million (US$1.7 million), compared to no revenues for the third quarter of 2010.

The Vancouver, British Columbia-based firm derived all of its revenues from licensing. During the quarter it received license fees and research reimbursement of C$2.3 million from Precision Therapeutics, "half of which is credited against future royalties" that it may receive from Precision, Med BioGene said in a statement accompanying its results.

Earlier this year Med BioGene inked an exclusive licensing deal with Precision Therapeutics covering its LungExpress Dx test. The gene expression-based test has been developed to identify patients with early-stage non-small-cell lung cancer, who following surgical removal of their tumors, are at higher or lower risks of mortality.

Under terms of the agreement, Precision Therapeutics agreed to pay Med BioGene C$2.3 million in licensing fees and research reimbursements within 120 days of the deal's closing. Med BioGene is also eligible for royalty payments.

Med BioGene reported net income of C$1.6 million, or C$.02 per share, for the quarter, compared to a net loss of C$1.7 million, or C$.02 per share, for Q3 2010.

Its R&D spending for the quarter plummeted to C$14,511 from C$194,224, and its general and administrative costs fell sharply to C$183,958 from C$1.5 million.

Med BioGene finished the quarter with C$853,317 in cash and cash equivalents.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.